» Articles » PMID: 22276947

Imbalance of Regulatory T Cells to Th17 Cells in IgA Nephropathy

Overview
Publisher Informa Healthcare
Specialty Science
Date 2012 Jan 27
PMID 22276947
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Dysregulation of CD4 (+) T cell subsets participates in the pathogenesis of IgA nephropathy (IgAN). FoxP3 (+) regulatory T cells (Treg) and Th17 cells are two novel subsets of CD4 (+) T cells. This study aims to investigate Treg/Th17 balance in IgAN patients.

Methods: Peripheral frequencies of Th17 and Treg functional subsets - CD45RA (+) FoxP3(low) resting Treg (rTreg) and CD45RA(-)FoxP3(high) activated Treg (aTreg) were assessed in 63 adult IgAN patients. Expression of transcription factors (FoxP3 and RORγt) and related cytokines of Treg and Th17 were analysed. Renal expression of FoxP3 and IL-17A were detected by immunohistochemistry.

Results: Compared with normal controls, IgAN patients had decreased frequency of CD45RA(-)FoxP3(high) aTreg subset (p < 0.05), increased frequency of Th17 (p < 0.05) and decreased ratio of Treg/Th17 (p < 0.05). Frequency of aTreg subset correlated with SBP(r = - 0.57, p < 0.05), DBP (r = - 0.50, p < 0.05), eGFR (r = 0.68, p < 0.05) and 24 h proteinuria (r = - 0.58, p < 0.05). RORγtmRNA/FoxP3mRNA ratio increased in IgAN (p < 0.05). Serum IL-17A, IL-21, IL-23, IL-1β and IL-6 elevated while IL-10 decreased in IgAN (p < 0.05), and serum IL-17A correlated with 24 h proteinuria (r = 0.35, p < 0.05). Serum TGF-β1 wasn't different between the two groups. Renal interstitial infiltration of FoxP3 (+) mononuclear cells were observed in IgAN patients, particularly prominent in those with > 25% tubular atrophy/interstitial fibrosis. Tubular IL-17A expression was found in 34 out of 63 IgAN patients. Compared with 29 patients without IL-17A expression, these patients had lower renal function, greater proteinuria, and more severe tubulointerstitial damage.

Conclusions: Imbalance of Treg/Th17 found in IgAN may play a role in disease pathogenesis and progression.

Citing Articles

Identification of susceptibility loci and relevant cell type for IgA nephropathy in Han Chinese by integrative genome-wide analysis.

Li M, Hao X, Shi D, Cheng S, Zhong Z, Cai L Front Med. 2024; 18(5):862-877.

PMID: 39343836 DOI: 10.1007/s11684-024-1086-2.


Serum soluble interleukin-2 receptor alpha may predict tubulointerstitial inflammatory cell infiltration and short-term disease progression in immunoglobin A nephropathy.

Xu C, Pan K, Li J, Li Y, Jin S, Shi Y Immunol Res. 2024; 72(6):1350-1364.

PMID: 39276201 PMC: 11618199. DOI: 10.1007/s12026-024-09533-1.


Causal role of immune cells in IgA nephropathy: a mendelian randomization study.

Shu J, Ge Y, Wu Y Ren Fail. 2024; 46(2):2381593.

PMID: 39039855 PMC: 11268262. DOI: 10.1080/0886022X.2024.2381593.


Sequential administration of paricalcitol followed by IL-17 blockade for progressive refractory IgA nephropathy patients.

Uriol-Rivera M, Obrador-Mulet A, Julia M, Daza-Cajigal V, Delgado-Sanchez O, Garcia Alvarez A Sci Rep. 2024; 14(1):4866.

PMID: 38418932 PMC: 10902332. DOI: 10.1038/s41598-024-55425-7.


Identification of inflammatory biomarkers in IgA nephropathy using the NanoString technology: a validation study in Caucasians.

Gaumond L, Lamarche C, Beauchemin S, Henley N, Elftouh N, Gerarduzzi C Inflamm Res. 2024; 73(3):447-457.

PMID: 38291238 PMC: 10894174. DOI: 10.1007/s00011-023-01848-3.